secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiniksa Pharmaceuticals International, plc (KNSA)
CIK:        0001730430
Form:       8-K
Filed at:   2021-07-06T23:59:59+00:00
Accession:  0001104659-21-089476
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kiniksa shareholders elect directors, ratify auditor, approve exec pay, adopt annual say-on-pay vote
--------------------------------------------------------------------------------

- Felix J. Baker, Tracey L. McCain, Kimberly J. Popovits elected as Class III directors with ~32.8M, 35.9M, 35.8M votes for, respectively.
- PricewaterhouseCoopers LLP ratified as auditor for FY2021: 44.3M for, 66K against, 21K abstain.
- Non-binding advisory vote on executive compensation approved: 40.6M for, 625K against, 24.7K abstain.
- Shareholders recommended annual say-on-pay votes (40.9M for one year); board adopts annual frequency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730430/000110465921089476/0001104659-21-089476-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730430/000110465921089476/tm2121366d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-089476

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer